Return to homepagePandemic Pact

Harnessing optimal immunity for protection from life-threatening respiratory virus infections

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA396193

Grant search

Key facts

  • Disease

    COVID-19, Unspecified

  • Start & end year

    2025
    2029

  • Known Financial Commitments (USD)

    $1,878,742.94

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    University of Melbourne

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Respiratory viruses such as influenza and SARS-CoV-2 are constant threats to global health. Based on our pioneering studies, cutting-edge technologies and powerful clinical cohorts, this project will define optimal immunity against respiratory viruses, with a focus on protective killer T cells. We will identify key factors in life-threatening disease and decipher susceptibility in high-risk populations. This work will inform designs of new vaccines and therapies against severe viral infections.